Question 1

What is the catalog number for 4-Iodo Suberoylanilide Hydroxamic Acid?

Accepted Answer

The catalog number for 4-Iodo Suberoylanilide Hydroxamic Acid is 014903.

Question 2

What sizes are available for 4-Iodo Suberoylanilide Hydroxamic Acid?

Accepted Answer

4-Iodo Suberoylanilide Hydroxamic Acid is available in the following size(s): 100 mg.

Question 3

Is 4-Iodo Suberoylanilide Hydroxamic Acid in stock?

Accepted Answer

4-Iodo Suberoylanilide Hydroxamic Acid is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What happens if this product doesn’t perform as expected in my experiment?

Accepted Answer

Send us the catalogue number, product name, lot number, and a summary of your results. Our technical support team will investigate and, where needed, involve the manufacturer. This is covered under our guarantee provided the product was used before its expiry date and stored correctly.

Question 5

Is this product classed as hazardous or restricted for shipping?

Accepted Answer

Some products are subject to special import/export regulations, dangerous goods handling, or licensing requirements. Where this applies, it’s noted on the product page, and any required extra documents or fees will be confirmed with you before dispatch, never added without your consent.

Question 6

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

4-Iodo Suberoylanilide Hydroxamic Acid

Product Specifications

Frequently Asked Questions

Explore Other Products

SGK2 Polyclonal Antibody

SGK2 Polyclonal Antibody

SGK2 Polyclonal Antibody

Thiobenzoic Acid (94%)(Benzenecarbothioic Acid)

Cytokeratin 15 (Esophageal Squamous Cell Carcinoma Marker) (KRT15/2554), CF568 conjugate, 0.1mg/mL

Elab Fluor® 647 Anti-Mouse TNFα Antibody[XT3.11]